Ceapro Inc (CRPOF) 0.1788 $CRPOF Beta-glucan Market:

New Post Public Reply Private Reply Replies (0) Message Board

Oct 11, 2015 at 6:01 AM

Ceapro Inc (CRPOF) 0.1788 $CRPOF

Beta-glucan Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025
M2 - Wed Sep 09, 6:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lgwrnv/betaglucan) has announced the addition of the "Beta-glucan Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025" report to their offering. This report examines the global beta-glucan market for the period 2015-2025. The primary objective of the report is to offer updates on the advancements in the food industry that have given rise to utilization of natural ingredient: beta-glucan, which is significantly fulfilling consumer demands for functional food ingredients. The market is expected to register a CAGR of 7.0% during the projected period. This study demonstrates the market dynamics and trends in all the seven region, which influence the current nature and future status of the beta-glucan over the forecast period. Beta-glucan is a polysaccharide that is found in natural source such as oats, barley, mushroom and yeast. The physicochemical properties of beta-glucan vary depending on characteristics of primary structure, including linkage type, degree of branching and molecular weight. Key Segments Covered By Source Cereal Oats Barley Yeast Others (mushroom) By functionality Soluble beta-glucan Insoluble beta-glucan By Application Food & Beverages Bakery Products Health & Dietary Supplements Dairy & Frozen Products Cosmetics & Personal Care Others ( Animal Feed) Key Companies Associated British Foods Plc. Biotec Pharmacon ASA (Biotec BetaGlucans AS) Biothera the Immune Health Company Ceapro Inc. Immuno Medic AS Koninklijke DSM N.V. Super Beta Glucan (SBG) Inc. Groupe Soufflet S.A (AIT Ingredients) Tate & Lyle plc. (Tate & Lyle Oats Ingredients) Zilor Inc. (Biorigin) For more information visit http://www.researchandmarkets.com/research/lgwrnv/betaglucan

Ceapro Presents Unique Advantages of Pressurized Gas Expanded Technology (PGX) at the 12th Annual BIO World Congress on Industrial Biotechnology
Marketwired - Tue Jul 21, 3:06PM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, presented the unique advantages of its proprietary and novel Pressurized Gas eXpanded (PGX) platform processing technology at the 12th Annual BIO World Congress on Industrial Biotechnology in Montreal, Canada.
CZO.VN: 0.240 (+0.020)

Ceapro to Present on Pressurized Gas Expanded Technology (PGX) at the 12th Annual BIO World Congress on Industrial Biotechnology
Marketwired - Thu Jul 09, 7:05AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that an abstract on its novel Pressurized Gas eXpanded (PGX) platform processing technology will be presented at the 12th Annual BIO World Congress on Industrial Biotechnology being held July 19-22, 2015, at the Montreal Convention Center, in Montreal, Canada.
CZO.VN: 0.240 (+0.020)

Ceapro Featured at the 12th International Congress on Engineering and Food (ICEF12)
Marketwired - Mon Jun 15, 7:02AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced its featured participation in the 12th International Congress on Engineering and Food (ICEF12) being held June 14-18, 2015, at the Quebec City Convention Centre in Quebec City, Canada.
CZO.VN: 0.240 (+0.020)

Ceapro Announces Election of Directors at 2015 Shareholders' Meeting
Marketwired - Tue Jun 09, 7:03AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that all proposed Directors, Mr. Gilles Gagnon, Dr. Ulrich Kosciessa, Dr. William W. Li, Mr. Don Oborowsky, Mr. Glenn R. Rourke and Mr. John Zupancic, were elected to serve for a one-year term at its annual meeting of shareholders held on June 3, 2015.
CZO.VN: 0.240 (+0.020)

Ceapro Inc. Reports First Quarter 2015 Financial and Operations Results
Marketwired - Mon Jun 01, 8:02AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today its financial results for the three-months ended March 31, 2015 and provided an overview of recent operational highlights.
CZO.VN: 0.240 (+0.020)

Ceapro to Develop Enabling Pressurized Gas Expanded Technology (PGX) at Commercial and Demonstration Scale
Marketwired - Thu May 28, 6:05AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for the healthcare and cosmetic industries, announced today it will embark on a scale-up of its proprietary PGX technology to commercial and demonstration levels.
CZO.VN: 0.240 (+0.020)

Ceapro Announces Appointment of New Chief Financial Officer
Marketwired - Tue May 05, 6:06AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today it has appointed Stacy Prefontaine, CA, as Chief Financial Officer. Ms. Prefontaine replaces Branko Jankovic who is leaving his position effective immediately.
CZO.VN: 0.240 (+0.020)

Ceapro Appoints Seasoned Pharmaceutical Industry Executive, Ulrich Kosciessa, Ph.D., to its Board of Directors
Marketwired - Tue Apr 28, 7:03AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today it has appointed international pharmaceutical industry expert, Ulrich Kosciessa, Ph.D., to its Board of Directors.
CZO.VN: 0.240 (+0.020)

Ceapro Reports Record Full-Year 2014 Financial Results
Marketwired - Wed Apr 22, 7:02AM CDT
Ceapro Inc. (TSX VENTURE: CZO) (Ceapro or the Company), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today its financial results for the twelve-months ended December 31, 2014 and provided an overview of recent operational highlights and expected business milestones for 2015.
CZO.VN: 0.240 (+0.020)

Ceapro Expands License Agreement With University of Alberta for PGX Technology
Marketwired - Wed Feb 11, 7:03AM CST
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced an expansion to its agreement with the University of Alberta for the development and commercialization of an innovative drying technology called Pressurized Gas eXpanded Technology (PGX) to include all fields of use, including emerging industrial opportunities. The original agreement was established in April 2014 for the development and commercialization of the PGX technology in select large markets like cosmeceuticals, functional food, nutraceuticals and pharmaceuticals.
CZO.VN: 0.240 (+0.020)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SWI Compute's Bold Move: Transforming Power Into AI

The Power Play: From Grid to AI If you think turning megawatts into money-making machines is a stretch, think again. SWI Compute is daringly striding into this territory with the launch of its NVIDIA AI factories in Europe, backed by a hefty 3.6 gigawatts of secured power capacity. It's not just talk; they've got the juice, both in electricity and ambition, to boot....

AppLovin Faces Securities Class Action Amid Share Plunge

AppLovin's Fall from Grace AppLovin Corporation's recent tumble from investor darling to beleaguered party in a securities class action isn’t just a misstep; it’s a full-fledged nosedive into troubled waters that no trader worth their salt would want to ignore. The story kicks off with a pair of sharply disappointing turns that sent shivers down the spines of anyone...

Shure Leads AI-Enabled Smart Hardware for Hybrid Meetings

Shure's Leap into AI-Powered Hybrid Meetings It’s not every day you hear about an old-school audio company leading the charge in AI technology, yet here we have Shure, flexing its muscles in the IDC MarketScape for AI-enabled conference gear. This move isn't just a head-nod to their century-plus in audio; it's them steelin' up for the modern hybrid work battlefield....

Costa Rican Firms Target Aerospace Supply Chain Gains

Today's spotlight swings on a gutsy move by 10 Costa Rican aerospace companies hustling for a foothold on the global stage. These folks aren't just sitting back; they're throwing their hats in the ring at the NBAA-BACE shindig down in the neon glare of Las Vegas, aiming to muscle into the aerospace supply chain — a cold, hard leap that's a mix of grit and ambition....

Surgery Partners Buyout: Fair Deal or Insider Jackpot?

What's Going On With Surgery Partners? Alright, here's the scoop that shareholders can't ignore—Surgery Partners (NYSE:SGRY) could be heading under the scalpel itself with a proposed buyout by HealthSpan. For those holding onto SGRY stock, this might feel like watching the rerun of a medical drama where the ending ain't clear yet. Shareholders are set to get $23.50 a...

Temu Partners with Recyclia to Drive EPR Compliance Boost

Temu and Recyclia: Building a Sustainable Marketplace Get this: Temu, the e-commerce giant you've heard trumpeting about affordable goods like some digital bazaar, is diving deeper into sustainability waters with a partner that knows a thing or two about waste. This time, they've linked up with Recyclia over in Spain. The duo's focus? Helping marketplace sellers meet the...

Cleveland Youth Team Uses Global Catch for Fundraising

Turning a Simple Game into a Global Campaign Sometimes, you just need a fresh angle to hit a home run, and that's what Thunder Baseball is counting on. The Cleveland-based 501(c)(3) youth baseball organization is ditching the old fundraising playbook. No more cookie-cutter raffles or bake sales. Instead, they’re launching a campaign that taps into the universal joy of...

Duke Energy's Battle Against Energy Vampires Heats Up

Unplugging Hidden Electricity Drains Ever wonder why your electric bill has been sneakily creeping up? You might think it's just the AC running full blast or lights left on, but surprise, surprise—there’s a whole army of “energy vampires” quietly sucking the juice out of your home. Duke Energy Florida is drawing attention to this sneaky leak, especially around...

Graybar's Q3 2026: Soaring Profits and Strategic Moves

Breaking Records and Boosting Confidence Graybar's firing on all cylinders, hitting record highs in both net sales and income for the second straight quarter. If you're watching this stock, put it on your radar because they've hit a mighty $4 billion in net sales this third quarter. That's a hefty 22% jump compared to last year, and net income ain't shy either—they...

HONOR X9e Pro Unveils with Massive Battery Power

Lighting Up the Sky: HONOR's Big Move Picture this: the Burj Khalifa in Dubai, world’s tallest building, flashing with the promise of a smartphone's monstrous battery. That’s what the fine folks at HONOR did, highlighting their X9e Pro and its mind-boggling 11,000mAh battery. Now, am I the only one who finds it more than a little audacious to leverage such a flashy...